Page 8 - IJCS Journal Vol.1.cdr
P. 8

theijcs.com                                                   The IJCS / Vol 1 / Issue 1



                                        GYNAECOLOGICAL CANCERS




             Dr Sandeep Kaur, MD
             Assistant Professor. Deptt. Of Radiotherapy.
             GMC Jammu


             Contributing Authors Affiliations:
             N/A

                      Developing  countries  account  for  approximately  77.7%  of  global  estimate  for  new  cases  of  the
       commonest gynaecological cancers including cervix, uterus and ovarian cancers.  These cancers account for 25% of
       all new cancers diagnosed in women aged 65 years compared with 16 % in the developed world.

                      Indian  National  Cancer  Control  Programme  emphasizes  the  importance  of  early  detection  and
       treatment, but there is no organized screening  programme, and the majority of Indian women lack both awareness
       about  the  disease  and  access  to  prevention  and  treatment  facilities  (like  HPV  Vaccines,  PAP  smears,  genetic

       counseling etc).
                      The  last  few  years  have  witnessed  a  better  understanding  of  molecular  events  that  cause
       gynaecological cancers and new insights are changing the practice of Gynaecological Oncology. Regardless of

       cancer origin ,or age at onset, the disease and its treatment   can produce short and long term sequelae ( sexual
       dysfunction, infertility, lymphoedema  etc. ) that adversely affect Quality Of Life ( QOL). . The implementation of new
       concepts into our daily practice may improve treatment received by patients and more importantly it could influence

       their survival and QOL ,which should be our final end point.
                      The challenges faced by Oncologists at many centres in India ,are ,the late presentation of cases,
       noncompliance with treatment regimens ,lack of use of cutting edge cytotoxic drugs, the poor outcome of radical

       surgeries and lack of functional , uptodate Radiotherapy facilities. The above factors contribute to create a very difficult
       Gynaecological Cancer Care environment   in many places. In addition comprehensive discussion on tackling the
       complex problems like drug resistance, emerging role of Immunotherapy,   SLN Biopsies and issues of complete

       surgeries and adequate Lymphadenectomy and Precision Radiotherapy techniques , is the need of the hour.
                      The aim of this didactic scientific discussion is to update the knowledge of the treating Oncologists and
       to ensure that Preventive and Screening protocols are percolated to the concerned population, so that together we can

       combat this disease !












             Corresponding Author
             Dr Sandeep Kaur, MD
             Assistant Professor. Deptt. Of Radiotherapy.
             GMC Jammu
             Fellow UCSD San Diego California, USA.







                         The Integrated Indian Journal of Cancer Sciences
   3   4   5   6   7   8   9   10   11   12   13